24.95MMarket Cap
LossP/E TTM
BTAI Financials
See BioXcel Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
BioXcel Therapeutics Inc Earnings Date
Latest Release
May 15, 2026
EPS / Forecast
-0.54/-0.82
Revenue / Forecast
206.00K/349.25K
Revenue(YoY)
642.00K
-71.67%
Analyst Rating
BUY
2026/07/31
FAQs
What is the total revenue of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its total revenue reached 642.00K, with a year-on-year change of 2.27M.
What are the current assets of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its current assets were 44.69M, with a year-on-year change of 19.50.
What are the total assets of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its total assets of BioXcel Therapeutics Inc were 44.92M, with a year-on-year change of 17.16.
What are the total liabilities of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its total liabilities of BioXcel Therapeutics Inc were 140.38M, with a year-on-year change of 6.80.
What is the total equity of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its total equity of BioXcel Therapeutics Inc was -95.46M, with a year-on-year change of -2.54.
What is the net operating income of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its net operating income of BioXcel Therapeutics Inc was -50.27M, with a year-on-year change of 22.43.
What is the net financing of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its net financing of BioXcel Therapeutics Inc was 56.52M, with a year-on-year change of 54.17.
What is the Earnings Per Share (EPS) of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -5.73, with a year-on-year change of 98.48.
What is the net income of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its net income was -69.90M, with a year-on-year change of -17.28.
What is the net margin of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its net profit margin was -10887.38, with a year-on-year change of -313.95.
What is the gross margin of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its gross margin was 74.45, with a year-on-year change of 1271.66.
What is the debt-to-asset ratio of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 244.00, with a year-on-year change of -8.74.
What is the Return on Assets (ROA) of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -167.91, with a year-on-year change of -57.83.
What is the operating profit of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its operating profit was -50.27M, with a year-on-year change of 22.43.